Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China
· Delayed Price · Currency is CNY 9.11
-0.19 (-2.04%)
Jun 17, 2025, 2:45 PM CST
SHE:300942 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | 20.88 | 17.12 | -184.91 | 82.97 | 236.51 | 65.45 | Upgrade
|
| Depreciation & Amortization | 21.02 | 21.02 | 33.48 | 30.36 | 24.16 | 5.52 | Upgrade
|
| Other Amortization | 2.02 | 2.02 | 15.5 | 4.84 | 3.82 | 1.49 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.28 | -2.28 | -2.81 | -0.3 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.11 | 1.11 | 25.18 | 1.95 | 0 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | 3.98 | 3.98 | 54.08 | -2.68 | -9.66 | -8.82 | Upgrade
|
| Provision & Write-off of Bad Debts | 8.14 | 8.14 | 2.81 | 0.49 | 2.42 | 2.3 | Upgrade
|
| Other Operating Activities | 5.62 | 20.21 | 41.95 | 52.64 | 4.27 | 13.45 | Upgrade
|
| Change in Accounts Receivable | -20.85 | -20.85 | 24.71 | -29.25 | -38.91 | 5.93 | Upgrade
|
| Change in Inventory | 20.3 | 20.3 | 41.34 | -51.13 | -17.02 | -43.31 | Upgrade
|
| Change in Accounts Payable | -58.74 | -58.74 | -96.08 | 33.38 | 41.1 | -2.68 | Upgrade
|
| Change in Other Net Operating Assets | 19.26 | 19.26 | 7.89 | 36.8 | 8.8 | 27.14 | Upgrade
|
| Operating Cash Flow | 23.43 | 34.26 | -37.25 | 152.55 | 255.42 | 63.79 | Upgrade
|
| Operating Cash Flow Growth | -10.41% | - | - | -40.27% | 300.39% | -5.13% | Upgrade
|
| Capital Expenditures | -154.24 | -174.1 | -128.64 | -176.85 | -79.51 | -82.84 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.73 | 1.23 | 4.95 | 0.54 | - | 0.04 | Upgrade
|
| Divestitures | 0.71 | 0.35 | - | - | - | - | Upgrade
|
| Investment in Securities | -180.26 | -178.46 | 56.71 | -20.21 | -353.36 | - | Upgrade
|
| Other Investing Activities | 180.91 | 3.47 | 0.76 | 6.57 | 6.3 | 8.98 | Upgrade
|
| Investing Cash Flow | -151.14 | -347.52 | -66.23 | -189.95 | -426.57 | -73.82 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 22 | Upgrade
|
| Long-Term Debt Issued | - | 108.82 | 391.97 | 64 | - | - | Upgrade
|
| Total Debt Issued | 64.51 | 108.82 | 391.97 | 64 | - | 22 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -22 | Upgrade
|
| Long-Term Debt Repaid | - | -19.94 | -44.87 | -17.25 | -16.68 | - | Upgrade
|
| Total Debt Repaid | -22.39 | -19.94 | -44.87 | -17.25 | -16.68 | -22 | Upgrade
|
| Net Debt Issued (Repaid) | 42.12 | 88.88 | 347.09 | 46.75 | -16.68 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 195.74 | - | Upgrade
|
| Common Dividends Paid | -5.67 | -5.34 | -12.94 | -100.65 | -18.04 | -45 | Upgrade
|
| Other Financing Activities | 5.22 | 3.6 | -1.02 | 0.06 | -20.39 | -1.23 | Upgrade
|
| Financing Cash Flow | 41.67 | 87.14 | 333.13 | -53.85 | 140.64 | -46.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.57 | 1.5 | 4.92 | -0.81 | -4.5 | -10.28 | Upgrade
|
| Net Cash Flow | -81.46 | -224.62 | 234.57 | -92.05 | -35 | -66.53 | Upgrade
|
| Free Cash Flow | -130.81 | -139.85 | -165.89 | -24.29 | 175.92 | -19.04 | Upgrade
|
| Free Cash Flow Margin | -55.16% | -62.36% | -65.29% | -3.54% | 29.44% | -7.37% | Upgrade
|
| Free Cash Flow Per Share | -0.30 | -0.33 | -0.41 | -0.06 | 0.45 | -0.05 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0.37 | Upgrade
|
| Cash Income Tax Paid | - | -9.59 | 9.19 | 48.61 | 51.85 | 20.64 | Upgrade
|
| Levered Free Cash Flow | -178.22 | -184.34 | -97.59 | -69.03 | 101.15 | -44.16 | Upgrade
|
| Unlevered Free Cash Flow | -165.91 | -172.68 | -90.94 | -66.47 | 102.64 | -43.93 | Upgrade
|
| Change in Net Working Capital | 44.66 | 31.22 | -55.33 | -3.54 | 3.68 | 9.55 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.